Mesabi Trust (MSB) 15.28 $MSB Mesabi Trust Press

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mesabi Trust (MSB) 15.28 $MSB

Mesabi Trust Press Release
Business Wire - Tue Apr 14, 3:17PM CDT
The Trustees of Mesabi Trust (NYSE:MSB) have determined that no distribution will be declared in April 2015 with respect to Units of Beneficial Interest of Mesabi Trust. The Trustees' determination follows its previous decision to not pay a quarterly distribution for the same period last year and is a result of the Trustees' determination to make adequate provision for expenses and anticipated negative price adjustments which will be applied to future royalties, and to increase the Trust's unallocated reserve after considering the need to maintain adequate reserves as further described below.
MSB: 15.28 (+0.45)

Great Timing For Athersys, Other Stem Cell Companies Amidst Improving Regulatory Landscape
ACCESSWIRE - Mon Apr 13, 8:35AM CDT
WHITEFISH, MT / ACCESSWIRE / April 13, 2015 / The field of regenerative medicine holds great promise for developing new treatments for notoriously difficult-to-treat diseases and conditions where small molecules, immunotherapies and other disciplines still haven't been able to deliver a safe and efficacious impact. For instance, Athersys, Inc. (NASDAQ:ATHX) is now less than two weeks away from top-line data from a Phase 2 international trial on patients suffering an ischemic stoke, an often devastating condition where there are no FDA-approved treatments beyond a four hour treatment window from time of occurrence. Mesoblast Ltd. (OTC: MBLTY)(ASX: MSB) has five product candidates based on specialized cells called mesenchymal lineage adult stem cells in, or ready for, late-stage trials targeting difficult conditions, including congestive heart failure. In a blitz of biotech deals in the waning days of March, stem cells hit the headlines with Fujifilm agreeing to acquire Cellular Dynamics International (NASDAQ: ICEL) for $307 million, a heavy 108% premium to the prior day's closing price of ICEL, to gain control of one of the aspiring leaders in the stem cell research business. This follows on the announcement in early March of the new Athersys-Chugai partnership.
ICEL: 16.48 (-0.02), TEVA: 64.41 (+1.16), ATHX: 1.29 (-0.03), MSB: 15.28 (+0.45)

3 Hold-Rated Dividend Stocks: AI, SXCP, MSB
at The Street - Mon Apr 06, 10:31AM CDT
These 3 dividend stocks are rated a Hold by TheStreet
SXCP: 22.21 (+0.16), AI: 23.62 (-0.02), MSB: 15.28 (+0.45)

Downtrend Call Working As Mesabi Trust Stock Falls 26.2% (MSB)
Comtex SmarTrend(R) - Thu Apr 02, 9:53AM CDT
SmarTrend identified a Downtrend for Mesabi Trust (NYSE:MSB) on March 16th, 2015 at $16.71. In approximately 2 weeks, Mesabi Trust has returned 26.18% as of today's recent price of $12.34.
MSB: 15.28 (+0.45)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Apr 01, 11:45AM CDT

IMDZ: 26.56 (-0.42), UTIW: 9.27 (-0.14), VTNR: 2.54 (unch), SIEB: 1.90 (+0.01), OIBR: 2.05 (-0.01), AKAO: 6.36 (-0.04), EVRY: 0.18 (unch), MSB: 15.28 (+0.45), VLTC: 11.54 (+0.50), TRIL: 24.21 (+2.05), HKTV: 9.11 (+1.44), DYAX: 27.44 (-0.85), GBSN: 4.17 (-0.53), PRXI: 4.55 (-0.10), CTSO: 7.52 (+0.50), LIME: 2.83 (-0.06), SSP: 23.52 (+0.18), WLDN: 15.87 (-0.30), GDDY: 25.63 (+0.58), ERII: 3.22 (-0.15)

3 Hold-Rated Dividend Stocks: AI, MSB, ELRC
at The Street - Wed Mar 25, 10:30AM CDT
These 3 dividend stocks are rated a Hold by TheStreet
AI: 23.62 (-0.02), MSB: 15.28 (+0.45), ELRC: 10.89 (-0.28)

I'll Take Some Greenblatt With A Touch Of Domash
Thomas Pound - at Seeking Alpha - Sun Mar 22, 2:13AM CDT

HLF: 41.10 (-3.75), CRT: 22.20 (+0.08), STRA: 53.40 (-0.94), ASPS: 23.24 (+0.76), LO: 70.81 (-0.19), DHIL: 172.31 (+1.31), USNA: 128.29 (+0.17), CPSI: 53.60 (-0.18), HOV: 3.20 (unch), HLT: 30.28 (-0.03), COH: 42.65 (+0.28), LYB: 100.83 (+3.26), PBT: 9.51 (unch), WLKP: 28.76 (+0.09), CBOE: 57.25 (-0.39), TPL: 158.02 (+1.07), KBH: 14.88 (+0.11), BKE: 47.70 (unch), MA: 90.72 (-0.16), AMBA: 72.13 (-1.32), REV: 40.25 (-0.10), CXDC: 5.84 (-0.02), MNI: 1.48 (-0.05), STX: 58.34 (-0.41), MSB: 15.28 (+0.45), NRT: 13.31 (-0.04), CLB: 124.69 (-0.63), MCO: 107.50 (-0.26), PDLI: 7.02 (-0.09), BPI: 9.18 (-0.16), MJN: 97.94 (+1.53), NVO: 56.65 (+0.44), WTW: 8.25 (+0.15), EPAM: 66.61 (-0.95), TNH: 135.00 (+3.07), SJT: 11.30 (-0.34), BPT: 69.07 (-0.53), SDRL: 11.39 (-0.26), TAOM: 3.29 (+0.19), CHH: 62.68 (+0.41), SEMG: 85.27 (-0.86), DPZ: 113.96 (+4.73), ACN: 93.40 (-0.44), KING: 16.76 (-0.25), KGJI: 1.32 (+0.02), VOC: 6.20 (-0.18), ATL: 0.13 (unch), SBR: 41.47 (-0.10), KEYS: 34.99 (-0.45), DNB: 131.86 (-0.48), GAME: 6.85 (-0.01)

Mesoblast Selected for Fast Track Access to Potential Investment Incentives in Japan
GlobeNewswire - Wed Mar 18, 6:32PM CDT
Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced that it has been selected by the Japan External Trade Organization (JETRO) as the only regenerative medicine company worldwide to receive fast track access to potential investment incentives across all levels of government in Japan. Mesoblast will receive a specially tailored market and government incentive roadmap aimed at providing a more attractive business environment.
MSB: 15.28 (+0.45)

What To Hold: 3 Hold-Rated Dividend Stocks EFC, NYMT, MSB
at The Street - Fri Mar 13, 10:30AM CDT
These 3 dividend stocks are rated a Hold by TheStreet
EFC: 20.26 (+0.11), MSB: 15.28 (+0.45), NYMT: 7.89 (+0.04)

What To Hold: 3 Hold-Rated Dividend Stocks BKEP, FGP, MSB
at The Street - Tue Mar 03, 9:30AM CST
These 3 dividend stocks are rated a Hold by TheStreet
BKEP: 8.02 (-0.33), FGP: 24.53 (+0.22), MSB: 15.28 (+0.45)

3 Hold-Rated Dividend Stocks: WHF, FGP, MSB
at The Street - Mon Feb 09, 10:07AM CST
These 3 dividend stocks are rated a Hold by TheStreet
WHF: 12.70 (+0.05), FGP: 24.53 (+0.22), MSB: 15.28 (+0.45)

3 Hold-Rated Dividend Stocks: MTGE, FGP, MSB
at The Street - Fri Jan 30, 9:42AM CST
These 3 dividend stocks are rated a Hold by TheStreet
MTGE: 18.09 (-0.02), FGP: 24.53 (+0.22), MSB: 15.28 (+0.45)

What To Hold: 3 Hold-Rated Dividend Stocks FLY, ANH, MSB
at The Street - Thu Jan 22, 9:30AM CST
These 3 dividend stocks are rated a Hold by TheStreet
ANH: 5.24 (+0.02), FLY: 15.12 (+0.18), MSB: 15.28 (+0.45)

Mesabi Trust declares $0.64/unit distribution
Seeking Alpha - at Seeking Alpha - Fri Jan 16, 3:29PM CST

MSB: 15.28 (+0.45)

Mesabi Trust Declares Distribution
Business Wire - Fri Jan 16, 3:20PM CST
The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of sixty-four cents ($0.64) per Unit of Beneficial Interest ("Unit" payable on February 20, 2015 to Mesabi Trust's unitholders ("Unitholders" of record at the close of business on January 30, 2015. This compares to a distribution of fifty-seven cents ($0.57) per Unit for the same period last year.
MSB: 15.28 (+0.45)

A Change in Tides: New Coverage on MeadWestvaco, Mesabi Trust, Minerals Technologies, Molycorp and Monsanto
PR Newswire - Mon Dec 29, 7:40AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including MeadWestvaco (NYSE: MWV), Mesabi Trust (NYSE: MSB), Minerals Technologies (NYSE: MTX), Molycorp (NYSE: MCP), and Monsanto (NYSE: MON). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
MON: 118.46 (+0.97), MWV: 47.50 (+0.41), MCP: 0.99 (+0.15), MTX: 69.37 (-1.14), MSB: 15.28 (+0.45)

Oil And Gas Stocks: Buy When People Are Fearful
Blue Ridge Buffettologist - Seeking Alpha - Mon Dec 08, 1:07AM CST
A simple rule dictates my buying: Be fearful when others are greedy, and be greedy when others are fearful. And most certainly, fear is now widespread, gripping even seasoned investors. --Warren Buffett, New York Times Op-Ed from late 2008 ...
HK: 1.57 (-0.04), EXXI: 4.16 (+0.06), TLM: 7.89 (+0.01), MILL: 0.98 (unch), BBEP: 6.23 (-0.06), CLF: 6.03 (+0.47), SDRL: 11.39 (-0.26), MSB: 15.28 (+0.45), UAN: 13.73 (-0.11), GDP: 3.63 (-0.11), RIG: 16.40 (-0.57), CHK: 14.54 (unch), SWN: 25.78 (-0.63), BHI: 68.09 (-0.28)

Japanese Legislation Takes Effect for Expedited Approvals of Regenerative Medical Products
GlobeNewswire - Mon Nov 24, 7:07PM CST
Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) provided an update to the market on the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act (PMD Act) which takes effect today in Japan. This Act establishes a framework for expedited approval in Japan for regenerative medical products.
MSB: 15.28 (+0.45)

What To Hold: 3 Hold-Rated Dividend Stocks WHF, LRE, MSB
at The Street - Mon Nov 10, 9:30AM CST
These 3 dividend stocks are rated a Hold by TheStreet
LRE: 8.69 (+0.11), WHF: 12.70 (+0.05), MSB: 15.28 (+0.45)

3 Hold-Rated Dividend Stocks: VLCCF, MSB, EVEP
at The Street - Wed Oct 29, 10:31AM CDT
These 3 dividend stocks are rated a Hold by TheStreet
EVEP: 17.43 (+0.29), VLCCF: 5.00 (unch), MSB: 15.28 (+0.45)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SOTERIA Launches Cancer Hunt™ for Military Patients

Updated Category News Views 66

Breaking the Barriers for Our Military's Cancer Fight Diving into the world of precision medicine, SOTERIA Precision Medicine Foundation has sparked a revolution with Cancer Hunt™. It's staggering to think about the piles of bureaucracy and insurance red tape that often stand between cancer patients and life-saving care. Especially when those patients are veterans or...

Continue Reading
Barco Brings HDR Cinema Home with Kinepolis Kortrijk

Updated Category News Views 230

A New Chapter in Cinema Projection Ah, Belgium, the land of waffles and apparently, cutting-edge cinema tech. That's right, Barco is bringing their HDR by Barco system to its own backyard in Kortrijk, teaming up with Kinepolis to shake things up. It's not just any expansion—it's a homecoming of sorts. The company's laser cinema magic has already made face time in the...

Continue Reading
Hanwha's Big Bet: Tokenizing Real-World Assets with Chainlink

Updated Category News Views 39

Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....

Continue Reading
Banco Santander's Troubles: Legal Heat on SAN

Updated Category News Views 129

Brazilian Turbulence Shakes Banco Santander Imagine getting hit twice in a single week, once by a surprise election result and again by numbers that don't add up. That's the gut-wrenching scenario Banco Santander's (NYSE: SAN) investors are facing. After Brazil's unexpected election outcome, investor jitters translated into a 3.7% drop on October 26, 2026. Not two days...

Continue Reading
JAS Hits Top 1% in EcoVadis Sustainability Rankings

Updated Category News Views 57

A Platinum Performance in EcoVadis Ratings JAS Worldwide, hustling around in the logistics and supply chain sector, just nailed a spot in the much-coveted top 1% bracket for sustainability according to EcoVadis. We’re talking about a company that’s not only steering the mammoth ships of logistics but now it’s also wearing sustainability like a crown. This...

Continue Reading
Kuvings Unveils Hands-Free Juicer for Healthy Living

Updated Category News Views 0

A Fresh Squeeze in the Juice World If you've ever wanted something that makes that morning juice without you running a marathon in your own kitchen, Kuvings might just have the answer with their new AUTO10 SQUARE™ Plus. Announced on October 30, 2026, this isn't just another fancy named gadget—it actually shakes things up with a hands-free design that’s tailored for...

Continue Reading
Birth Injury Lawsuit Secures $19.1M Award in Michigan

Updated Category News Views 30

Legal Triumph for Sokolove's Birth Injury Case There are days when you see a win in the courtroom and think maybe, just maybe, justice ain't just a fairytale. Today, that thought knocks heavier with news rolling out of Michigan—an astronomical $19.1 million awarded to a family by a federal judge after a botched birth led to lifelong medical issues. You've got Sokolove...

Continue Reading
Geolava, Vaidio, Sensoneo Triumph in Texas Pitch Contest

Updated Category News Views 98

North Texas Lights the Innovation Torch Big moves are happening in North Texas, with a pitch competition that's more than just smoke and mirrors. We're talking about an arena where regional challenges meet cutting-edge solutions, and out of a global mix, Geolava, Vaidio, and Sensoneo snagged the 2026 North Texas Connected Innovation Pitch Contest crown. It's high stakes...

Continue Reading
Cohere's CAD $7 Billion Raise Signals AI Power Shift

Updated Category News Views 149

Changing the Game: Cohere's Massive Series E Raise There's a seismic shift happening up north, and it’s not the aurora borealis. Cohere just announced the initial close of a staggering CAD $7 billion Series E funding round, eyeing a CAD $35.7 billion valuation. If it pans out, it’d be the kind of cash grab that's never been seen in Canadian tech history. Why This...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 115

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading

Top 5 Most Recently Viewed Articles

Artiva Biotherapeutics Highlights Participation in Key Conference

Updated Category News Views 166

Artiva Biotherapeutics to Showcase at Annual Health Care Conference Artiva Biotherapeutics, Inc. (NASDAQ: ARTV), a pioneering clinical-stage biotechnology firm, is set to make a significant presence at the TD Cowen 45th Annual Health Care Conference. The event will be held on a Wednesday in the near future, featuring Artiva’s management team who will deliver a...

Continue Reading
Propel Holdings Achieves Remarkable Growth and Dividend Boost

Updated Category News Views 212

Propel Holdings Reports Impressive Financial Results Propel Holdings Inc. (TSX: PRL) has achieved remarkable financial results in its latest quarter, marked by record revenue and an increase in its dividend, showcasing its commitment to supporting underserved consumers. The fintech company, which operates various brands and platforms, has successfully navigated a...

Continue Reading
Ladder Capital Corp's Q3 2024 Financial Performance Revealed

Updated Category News Views 81

Ladder Capital Corp Reports Strong Q3 2024 Financial Results Ladder Capital Corp (NYSE: LADR) has announced its operating results for the quarter that recently concluded. The company reported a GAAP income before taxes of $28.5 million during this period, resulting in a diluted earnings per share (EPS) of $0.22. Additionally, Ladder achieved $37.7 million in distributable...

Continue Reading
IQSTEL Achieves $57.6M in Q1 Revenue, Eyes $1 Billion by 2027

Updated Category News Views 183

IQSTEL Reports Robust Q1 Revenue Performance IQSTEL Inc. (NASDAQ: IQST), a leading multinational technology and telecommunications provider, recently unveiled its Q1 revenue results. The company earned an impressive $57.6 million, showcasing a 12% year-over-year increase, as mentioned in its inaugural NASDAQ shareholder letter. A Vision for $1 Billion Revenue CEO Leandro...

Continue Reading
WesBanco's Growth Boosted by Successful Premier Acquisition

Updated Category News Views 223

WesBanco's Ambitious Expansion Strategy WesBanco, Inc. (NASDAQ: WSBC), a leading financial services provider, has recently undertaken a significant step in enhancing its regional presence. This transformation comes with the successful integration of Premier Financial Corp.'s approximately 400,000 consumer and 50,000 business accounts into its operations. This is a...

Continue Reading